References

Unresolved reference

2025 · External reference

The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017

10.1016/j.drugalcdep.2020.108350 · 2021 · External reference

Unresolved reference

2022 · External reference

Opioid use disorder with chronic pain increases disease burden and service use

10.1037/ser0000607 · 2023 · External reference

Comparison of opioid use disorder among male veterans and non-veterans: disorder rates, socio-demographics, co-morbidities, and quality of life

10.1111/ajad.12861 · 2019 · External reference

Chronic pain among patients with opioid use disorder: results from electronic health records data

10.1016/j.jsat.2017.03.006 · 2017 · External reference

The association of opioid use disorder and homelessness nationally in the veterans health administration

10.1016/j.drugalcdep.2021.108714 · 2021 · External reference

Unemployment rate, opioids misuse and other substance abuse: quasi-experimental evidence from treatment admissions data

10.1186/s12888-020-02981-7 · 2021 · External reference

Trends in opioid use disorder in the veterans health administration, 2005–2022

10.1001/jamanetworkopen.2024.51821 · 2024 · External reference

Problem opioid use among US military veterans: prevalence, correlates, and psychiatric characteristics

10.1097/adm.0000000000001286 · 2024 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2021 · External reference

Advancing the pain agenda in the veteran population

10.1016/j.anclin.2016.01.003 · 2016 · External reference

The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the national epidemiologic survey on alcohol and related conditions-III

10.1007/s00127-016-1208-5 · 2016 · External reference

Prevalence of substance misuse among US veterans in the general population

10.1111/ajad.12534 · 2017 · External reference

Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within veterans health administration facilities

10.1080/08897077.2020.1787299 · 2020 · External reference

Strategies to improve access to care for patients with opioid use disorder

10.1177/10600280241273258 · 2025 · External reference

Retention strategies for medications for opioid use disorder in adults: a rapid evidence review

10.1097/adm.0000000000000739 · 2021 · External reference

Drug overdose deaths in the United States, 2003–2023

10.15620/cdc/170565 · 2024 · External reference

Pharmacological and behavioral treatment of opioid use disorder

10.1176/appi.prcp.20180006 · 2019 · External reference

The management of substance use disorders: synopsis of the 2021 U.S. Department of veterans affairs and U.S. Department of defense clinical practice guideline

10.7326/m21-4011 · 2022 · External reference

Medications for opioid use disorder: bridging the gap in care

10.1016/s0140-6736(17)32893-3 · 2018 · External reference

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

10.1136/bmj.j1550 · 2017 · External reference

Unresolved reference

2020 · External reference

Retention of patients in opioid substitution treatment: a systematic review

10.1371/journal.pone.0232086 · 2020 · External reference

Meta-analysis of primary care delivered buprenorphine treatment retention outcomes

10.1080/00952990.2023.2251653 · 2023 · External reference

Buprenorphine use and courses of care for opioid use disorder treatment within the veterans health administration

10.1016/j.drugalcdep.2023.109902 · 2023 · External reference

Three-year retention in buprenorphine treatment for opioid use disorder nationally in the veterans health administration

10.1111/ajad.12553 · 2017 · External reference

Unresolved reference

2022 · External reference

Impact of treatment duration on mortality among veterans with opioid use disorder in the United States veterans health administration

10.1111/add.15574 · 2021 · External reference

Buprenorphine maintenance treatment of opiate dependence: correlations between prescriber beliefs and practices

10.3109/10826084.2015.1089905 · 2016 · External reference

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

10.1002/14651858.cd002207.pub4 · 2014 · External reference

Does retention matter? Treatment duration and improvement in drug use

10.1046/j.1360-0443.2003.00354.x · 2003 · External reference

Evaluating the optimal duration of medication treatment for opioid use disorder

10.1111/add.70211 · 2026 · External reference

Medication treatment of opioid use disorder

10.1016/j.biopsych.2019.06.020 · 2020 · External reference

Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: x the X waiver

10.1001/jamapsychiatry.2018.3685 · 2018 · External reference

Changes in methadone take-home dosing before and after COVID-19

10.1016/j.jsat.2021.108552 · 2022 · External reference

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder

10.1016/j.dadr.2023.100133 · 2023 · External reference

Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural northeastern United States: a qualitative study

10.1016/j.ssmmh.2022.100151 · 2022 · External reference

U.S. Military veteran perspectives on barriers and facilitators to medication treatment for opioid use disorder

10.1080/10826084.2025.2580518 · 2025 · External reference

Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: a qualitative study

10.1016/j.jsat.2021.108353 · 2021 · External reference

The effects of psychosocial services in substance abuse treatment

10.1001/jama.1993.03500150065028 · 1993 · External reference

The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): a nationwide veterans health administration cohort study

10.1016/j.drugalcdep.2022.109678 · 2022 · External reference

Treatment experiences among people who use opioids: a social ecological approach

10.1177/10497323221104315 · 2022 · External reference

Medications for opioid use disorder in the department of veterans affairs (VA) health care system: historical perspective, lessons learned, and next steps

10.1080/08897077.2018.1452327 · 2018 · External reference

Mobile health interventions for substance use disorders

10.1146/annurev-clinpsy-080822-042337 · 2024 · External reference

Potential and pitfalls of Mobile mental health apps in traditional treatment: an Umbrella review

10.3390/jpm12091376 · 2022 · External reference

Access, utilization, and interest in mHealth applications among veterans receiving outpatient care for PTSD

10.7205/milmed-d-14-00014 · 2014 · External reference

Veterans affairs and the department of defense mental health apps: a systematic literature review

10.1037/ser0000289 · 2019 · External reference

The cost-effectiveness of digital health interventions: a systematic review of the literature

10.3389/fpubh.2022.787135 · 2022 · External reference

Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic

10.1080/14737167.2021.1840357 · 2021 · External reference

Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder

10.1080/00325481.2021.1884471 · 2021 · External reference

Unresolved reference

2024 · External reference

Smartphone ownership, smartphone utilization, and interest in using mental health apps to address substance use disorders: literature review and cross-sectional survey study across two sites

10.2196/38684 · 2022 · External reference

Digital access among a national sample of currently and formerly homeless veterans in 2022

10.1177/14604582241276974 · 2024 · External reference

Mobile applications may be the future of veteran mental health support but do veterans know yet? A survey of app knowledge and use

10.1037/ser0000562 · 2022 · External reference

Veterans’ attitudes toward smartphone app use for mental health care: qualitative study of rurality and age differences

10.2196/10748 · 2018 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

External reference

A randomized clinical trial of smartphone self-managed recovery support services

10.1016/j.jsat.2020.108089 · 2020 · External reference

A smartphone application to support recovery from alcoholism: a randomized clinical trial

10.1001/jamapsychiatry.2013.4642 · 2014 · External reference

Unresolved reference

2026 · External reference

Good intentions are not enough: how informatics interventions can worsen inequality

10.1093/jamia/ocy052 · 2018 · External reference

Social disparities in internet patient portal use in diabetes: evidence that the digital divide extends beyond access

10.1136/jamia.2010.006015 · 2011 · External reference

Patient-perceived usefulness of online electronic medical records: employing grounded theory in the development of information and communication technologies for use by patients living with chronic illness

10.1197/jamia.m1712 · 2005 · External reference

The behaviour change wheel: a new method for characterising and designing behaviour change interventions

10.1186/1748-5908-6-42 · 2011 · External reference

Using the COM-B model and behaviour change wheel to develop a theory and evidence-based intervention for women with gestational diabetes (IINDIAGO)

10.1186/s12889-023-15586-y · 2023 · External reference

Sample size for qualitative research

10.1108/qmr-06-2016-0053 · 2016 · External reference

Sample sizes for saturation in qualitative research: a systematic review of empirical tests

10.1016/j.socscimed.2021.114523 · 2022 · External reference

Code saturation versus meaning saturation: how many interviews are enough?

10.1177/1049732316665344 · 2017 · External reference

Sample size in qualitative research

10.1002/nur.4770180211 · 1995 · External reference

Unresolved reference

2014 · External reference

Qualitative methods in implementation research: an introduction

10.1016/j.psychres.2019.112516 · 2019 · External reference

Thematic analysis and its reconceptualization as ’saliency analysis’

10.1258/jhsrp.2009.009081 · 2010 · External reference

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups

10.1093/intqhc/mzm042 · 2007 · External reference

Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown

10.1186/s13722-022-00296-4 · 2022 · External reference

Unresolved reference

2025 · External reference

Unresolved reference

2025 · External reference

Availability and quality of mobile health app privacy policies

10.1136/amiajnl-2013-002605 · 2015 · External reference

The national center for PTSD model for digital mental health: a public sector approach to development, evaluation, implementation, and optimization of resources for helping trauma survivors

10.1037/tra0001838 · 2025 · External reference

Adoption of Mobile apps for depression and anxiety: cross-sectional survey study on patient interest and barriers to engagement

10.2196/11334 · 2019 · External reference

Gamification in apps and technologies for improving mental health and well-being: systematic review

10.2196/13717 · 2019 · External reference

The use of gamification and incentives in Mobile health apps to improve medication adherence: scoping review

10.2196/30671 · 2022 · External reference

Examining the effectiveness of gamification in mental health apps for depression: systematic review and meta-analysis

10.2196/32199 · 2021 · External reference

Unresolved reference

2026 · External reference

Unresolved reference

2023 · External reference

A general inductive approach for analyzing qualitative evaluation data

10.1177/1098214005283748 · 2006 · External reference